Preparation and evaluation of mouth dissolving tablets of meloxicam

Authors

  • Prashant Khemariya Prashant Khemariya LNCT College of pharmacy Bhopal, India
  • Kavita R. Gajbhiye Dept. of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India
  • Vikas Deep Vaidya Dept. of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India
  • Rajesh Singh Jadon Dept. of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India
  • Sachin Mishra Bhagbant University Jaipur, India
  • Amit Shukla Indra gandhi College of Pharmaceutical Science, Bhubhaneshwar, India
  • Mohit Bhargava Ranbaxy Lab. Dewas, India
  • Sanjay K. Singhai Ranbaxy Lab. Dewas, India
  • Sanjay Goswami Ranbaxy Lab. Dewas, India

Keywords:

Mouth dissolving tablet, Maloxicam, Bioavailability, NSAID

Abstract

The aim of the present study was to develop evaluate mouth dissolving tablet of meloxicam. Drug delivery systems became sophisticated as pharmaceutical scientists acquire a better understanding of the physicochemical and biochemical parameters pertinent to their performance. Over the past three decades, mouth dissolving or orally disintegrating tablets have gained considerable attention as a preferred alternative to conventional tablets due to better patient compliance. The most preferrable route of drug administration (e.g. oral) is limited to drug candidate that show poor permeability across the gastric mucosa and those, which are sparingly soluble. A large majority of the new chemical entities and many new existing drug molecules are poorly soluble, thereby limiting their potential uses and increasing the difficulty of formulating bioavailable drug products,so lastlly the purpose of this study was to grow mouth dissolve tablets of Meloxicam. Meloxicam is a newer selective COX-1 inhibitor. These tablets were prepared by wet granulation procedure. The tablets were evaluated for % friability, wetting time and disintegration time. Sublimation of camphor from tablets resulted in better tablets as compared to the tablets prepared from granules that were exposing to vacuum. The systematic formulation approach helped in understanding the effect of formulation processing variables.

References

Birudaraj R, Berner B, Shen S, Li X. Buccal

permeation of buspirone: mechanistic studies on

transport pathways. J Pharm Sci. 2005;94:70-78.

Ishikawa T, Koizumi N, Mukai B. Pharmacokinetics of acetaminophen from rapidly disintegrating

compressed tablet prepared using microcrystalline

cellulose (PH-M-06) and spherical sugar

granules. Chem. Pharm Bull (Tokyo). 2001;49:230-

Price T.M., Blauer K.L., Hansen M., Stanczyk F., L

obo R., Bates G.W. Single-dose pharmacokinetics

of sublingual versus oral administration of

micronized17-beta-estradiol. Obstet Gynecol. 1997;

:340-345.

Habib,W., Khankari, R., Hontz, J. Fast-dissolving

drug delivery systems, critical review in

therapeutics, Drug Carrier Systems, 2000;17:61-72.

Chang, R., Guo, X., Burnside, B. A., Couch, R.

Fast-dissolving tablets, Pharm. Tech., 2000; 24:52-

Dobetti, L. Fast-Melting Tablets: Developments

and Technologies, Pharm. Tech., (Suppl.), 2001;

-50.

Corveleyn. S, Remon JP. Formulation and

production of rapidly disintegrating tablets by

lyophilization using hydrochlorothiazide as a model

drug. Int J Pharm. 1997;152: 215-225.

Remon JP, Corveleyn S. Freeze-dried rapidly

disintegrating tablets. US patent 6 010 719. January

, 2000.

Heinemann H, Rothe W. Preparation of porous

tablets. US patent 3 885 026. May 20, 1975.

Knistch A, Hagen E, Munz HD. Production of

porous tablets. US patent 4 134 843, January 16,

Roser BJ, Blair J. Rapidly soluble oral dosage

forms, method of making same, and composition

thereof. US patent 5 762 961. June 9, 1998.

Wallace JL. Prostaglandins, NSAIDs and

cytoprotection. Gastroenterol Clin. North Am.

;21: 631-641.

Troy M.Harmon .Beyond the first generations of

orally disintegrating Tablets. Emerging technology.

Tablets and Capsules, 3 Sep 2006.

Gothoskar, A.V., Parakh, S.R. A Review of mouth

dissolving tablet technologies. (Drug Delivery).

Pharmaceutical Technology.(Nov01/2003)

William R.P., Tapash .K. Ghosh. Orally

disintegrating tablets. Pharmaceutical Technology

(Product, Technologies, and Development issues in

Oct 2005).

Wayne C., Dipan R., Ann D. Selecting

superdisintegrants for Orally Disintegrating Tablet

Formulations in Phrmaceutical Technology Oct

/2006.

Jadon,R.S., Vaidya V.D., Khemariya P., Nayak S.

Taste Masking of Lornoxicam by Polymer Carrier

System and Formulation of Oral Disintegrating

Tablets. IJDD 2009; 1: 1-3

Downloads

Published

2010-03-31

How to Cite

Prashant Khemariya, Kavita R. Gajbhiye, Vikas Deep Vaidya, Rajesh Singh Jadon, Sachin Mishra, Amit Shukla, Mohit Bhargava, Sanjay K. Singhai, & Sanjay Goswami. (2010). Preparation and evaluation of mouth dissolving tablets of meloxicam. International Journal of Drug Delivery, 2(1), 76–80. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/15

Issue

Section

Original Research Articles